The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Analysis of the Efficacy of Aripiprazole and Quetiapine in the Treatment of Schizophrenia
Author(s): 
Pages: 292-293
Year: Issue:  3
Journal: OCCUPATION AND HEALTH

Keyword:  阿立哌唑奎硫平精神分裂症;
Abstract: 目的 分析阿立哌唑(奥派)治疗精神分裂症的疗效和安全性.方法 按照CCMD-3精神分裂症诊断标准选择80例住院和门诊精神分裂症患者,并随机分为阿立哌唑组和奎硫平(舒思)组分别进行治疗,疗程共8周.采用简明精神病评定量表(BPRS)进行疗效评定,采用不良反应症状量表(TESS)进行不良反应评定.结果 治疗8周后,阿立哌唑组和奎硫平组的疗效差异无统计学意义,不良反应差异亦无统计学意义.结论 阿立哌唑有显著改善精神分裂症症状的效果.
Related Articles
No related articles found